Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart
Why the study?
Do different glucometabolic states (known diabetes, newly diagnosed diabetes, or impaired glucose regulation) increase 1-year mortality in patients with coronary artery disease compared to normal glucose regulation?
Population
4,676 patients with coronary artery disease participating in the Euro Heart Survey on diabetes and the heart
Comparison
Known diabetes, newly diagnosed diabetes, or… vs Normal glucose regulation
Design
Cohort
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
Diabetes-associated mortality risk in CAD warrants attention but not practice change; leaves open whether IGR or glucose control affects outcomes.
Structured PICO
Do different glucometabolic states (known diabetes, newly diagnosed diabetes, or impaired glucose regulation) increase 1-year mortality in patients with coronary artery disease compared to normal glucose regulation?
P
Population
4,676 patients with coronary artery disease (CAD) participating in the Euro Heart Survey on diabetes and the heart
I
Intervention
Known diabetes, newly diagnosed diabetes, or impaired glucose regulation (IGR)
C
Comparator
Normal glucose regulation
O
Outcome
1-year mortalityhard clinical
In patients with coronary artery disease, both known and newly diagnosed diabetes independently predict 1-year mortality, whereas impaired glucose regulation does not.
Cite This Study
Lenzen et al. (2006) studied this question.